Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies

Authors:
  • RRRichard C. Reichman
    Richard C. Reichman
  • MFMargaret A. Fischl
    Margaret A. Fischl
  • MPMichael Para
    Michael Para
  • JLJohn Leedom
    John Leedom
  • LDLisa M. Demeter
    Lisa M. Demeter
  • LRLionel Resnick
    Lionel Resnick
  • YBYiannis Bassiakos
    Yiannis Bassiakos
  • JTJoseph Timpone
    Joseph Timpone
  • SCSteve Cox
    Steve Cox
  • DBDonald Batts
    Donald Batts

Abstract
No abstract available

This publication has 14 references indexed in Scilit: